[Pharmacological, pharmacokinetic, and clinical profile of itraconazole oral solution (ITRIZOLE Oral Solution 1%)].
Otani
Hisaya
H
HOTANI@JANJP.JNJ.com
Inoue
Kouichi
K
Shiota
Tetsuhiro
T
Suzuki
Yasumasa
Y
Nomura
Shunji
S
Harada
Yasushi
Y
Ishibashi
Hiroko
H
Abe
Shigeru
S
Uchida
Katsuhisa
K
Yamaguchi
Hideyo
H
Torii
Shinichi
S
D000284:Administration, Oral; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D002180:Candidiasis, Oral / Q000188:drug therapy* / Q000382:microbiology; D004195:Disease Models, Animal; D025141:Drug Resistance, Fungal; D005658:Fungi / Q000187:drug effects; D006801:Humans; D007408:Intestinal Absorption; D017964:Itraconazole / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D016032:Randomized Controlled Trials as Topic; D012996:Solutions
D000935:Antifungal Agents; D012996:Solutions; D017964:Itraconazole